The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Cyclic GMP Phosphodiesterase-5: Target of Sildenafil
Open accessAbstract
The advent of the medication, sildenafil, 1Tradename VIAGRA™. 1Tradename VIAGRA™. for treatment of male impotence has attracted widespread attention. This agent potently inhibits a cGMP-binding cGMP-specific phosphodiesterase (PDE5). 2The abbreviations used are: PDE, 3′:5′-cyclic nucleotide phosphodiesterase; PKA, cAMP-dependent protein kinase; PKG, cGMP-dependent protein kinase; IBMX, 3-isobutyl-1-methylxanthine 2The abbreviations used are: PDE, 3′:5′-cyclic nucleotide phosphodiesterase; PKA, cAMP-dependent protein kinase; PKG, cGMP-dependent protein kinase; IBMX, 3-isobutyl-1-methylxanthine PDE5 is particularly abundant in smooth muscle, which is enriched in other components of the cGMP signaling cascade. The characteristics of PDE5, its relationship to other PDEs, its role in cGMP signaling, and its involvement in the efficacious action of sildenafil on corpus cavernosum and vascular smooth muscle resulting in penile erection are the subjects of this review. Cyclic GMP has emerged recently as a principal focus in signal transduction. Much of this attention has derived from the fact that most of the non-lytic physiological effects of nitric oxide (Fig.1) and all of the characterized effects of natriuretic peptides and guanylins are mediated by cGMP. In addition to the classical regulatory roles ascribed to cGMP such as stimulation of smooth muscle relaxation, neutrophil degranulation, inhibition of platelet aggregation, and initiation of visual signal transduction, numerous other physiological roles have recently been uncovered (1Schultz K.D. Schultz K. Schultz G. Nature. 1977; 265: 750-751Crossref PubMed Scopus (333) Google Scholar, 2Lincoln T.M. Cornwell T.L. FASEB J. 1993; 7: 328-338Crossref PubMed Scopus (539) Google Scholar, 3Francis S.H. Corbin J.D. Murad F. Cyclic GMP: Synthesis, Metabolism and Function. Academic Press, Orlando, FL1993: 115-170Google Scholar, 4Lohmann S.M. Vaandrager A.B. Smolenski A. Walter U. de Jonge H.R. Trends Biochem. Sci. 1997; 22: 307-312Abstract Full Text PDF PubMed Scopus (348) Google Scholar, 5Hofmann F. Dostmann W. Keilbach A. Landgraf W. Ruth P. Biochim. Biophys. Acta. 1992; 1135: 51-60Crossref PubMed Scopus (104) Google Scholar, 6Furchgott R.F. Vanhoutte P.M. FASEB J. 1989; 3: 2007-2018Crossref PubMed Scopus (1665) Google Scholar, 7Garbers D.L. Lowe D.G. J. Biol. Chem. 1994; 269: 30741-30744Abstract Full Text PDF PubMed Google Scholar, 8Arnold W.P. Mittal C.K. Katsuki S. Murad F. Proc. Natl. Acad. Sci. U. S. A. 1977; 74: 3203-3207Crossref PubMed Scopus (1174) Google Scholar, 9Hobbs A.J. Ignarro L.J. Methods Enzymol. 1996; 269: 134-148Crossref PubMed Google Scholar, 10Moro M.A. Russel R.J. Cellek S. Lizasoain I. Su Y. Darley-Usmar V.M. Radomski M.W. Moncada S. Proc. Natl. Acad. Sci. U. S. A. 1996; 93: 1480-1485Crossref PubMed Scopus (419) Google Scholar). Intracellular receptors for cGMP include cGMP-dependent protein kinases (PKG), cyclic nucleotide-gated channels, and cGMP-binding PDEs; cGMP may also cross-activate cAMP pathways by binding to cAMP-binding sites on cAMP receptors such as cAMP-dependent protein kinases (PKA) (11Jiang H. Colbran J.L. Francis S.H. Corbin J.D. J. Biol. Chem. 1992; 267: 1015-1019Abstract Full Text PDF PubMed Google Scholar). Tissue cGMP levels are determined by a balance between the activities of the guanylyl cyclases that catalyze formation of cGMP from GTP and the cyclic nucleotide PDEs that catalyze the breakdown of cGMP (Fig. 1). The combination of a stimulator of guanylyl cyclase and a cGMP PDE inhibitor such as sildenafil produces synergistic enhancement of tissue cGMP levels (12Jeremy J.Y. Ballard S.A. Naylor A.M. Miller M.A. Angelini G.D. Br. J. Urol. 1997; 79: 958-963Crossref PubMed Google Scholar). PDEs were first detected by Sutherland and co-workers (13Rall T.W. Sutherland E.W. J. Biol. Chem. 1958; 232: 1065-1076Abstract Full Text PDF PubMed Google Scholar, 14Butcher R.W. Sutherland E.W. J. Biol. Chem. 1962; 237: 1244-1250Abstract Full Text PDF PubMed Google Scholar). The superfamily of PDEs is subdivided into two major classes, class I and class II (15Charbonneau H. Beavo J. Houslay M.D. Cyclic Nucleotide Phosphodiesterases: Structure, Regulation and Drug Action. John Wiley & Sons, Inc., New York1990: 267-296Google Scholar), which have no recognizable sequence similarity. Class I includes all known mammalian PDEs and is comprised of at least 10 identified families that are products of separate genes (16Beavo J.A. Conti M. Heaslip R.J. Mol. Pharmacol. 1994; 46: 399-405PubMed Google Scholar, 17Conti M. Nemoz G. Sette C. Vicini E. Endocr. Rev. 1995; 16: 370-389Crossref PubMed Scopus (316) Google Scholar, 18Degerman E. Belfrage P. Manganiello V.C. J. Biol. Chem. 1997; 272: 6823-6826Abstract Full Text Full Text PDF PubMed Scopus (380) Google Scholar, 19Houslay M.D. Adv. Enzyme Regul. 1995; 35: 303-338Crossref PubMed Scopus (34) Google Scholar, 20Bolger G.B. Cell. Signal. 1994; 6: 851-859Crossref PubMed Scopus (128) Google Scholar,
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Impotence and Its Medical and Psychosocial Correlates: Results of the Massachusetts Male Aging Study
Feldman, H. A., Goldstein, I., Hatzichristou, D. G., Krane, R. J., & McKinlay, J. B. (1994) · Journal of Urology · doi:10.1016/s0022-5347(17)34871-1 · Cited by 5,074
Adenosine 3‘,5‘-Phosphate in Biological Materials
Butcher, R. W., & Sutherland, E. W. (1962) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)60316-3 · Cited by 2,077
Endothelium‐derived relaxing and contracting factors
Furchgott, R. F., & Vanhoutte, P. M. (1989) · The FASEB Journal · doi:10.1096/fasebj.3.9.2545495 · Cited by 1,993
Arnold, W. P., Mittal, C. K., Katsuki, S., & Murad, F. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.8.3203 · Cited by 1,455
(1992) · doi:10.1126/science.1378650 · Cited by 1,163
Pai, E. F., Kabsch, W., Krengel, U., Holmes, K. C., John, J., & Wittinghofer, A. (1989) · Nature · doi:10.1038/341209a0 · Cited by 879
FORMATION OF A CYCLIC ADENINE RIBONUCLEOTIDE BY TISSUE PARTICLES
Rall, T. W., & Sutherland, E. W. (1958) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)77422-5 · Cited by 831
Intracellular cyclic GMP receptor proteins
Lincoln, T. M., & Cornwell, T. L. (1993) · The FASEB Journal · doi:10.1096/fasebj.7.2.7680013 · Cited by 653
Terrett, N. K., Bell, A. S., Brown, D., & Ellis, P. (1996) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/0960-894x(96)00323-x · Cited by 607
BALLARD, S. A., GINGELL, C. J., TANG, K., TURNER, L. A., PRICE, M. E., & NAYLOR, A. M. (1998) · Journal of Urology · doi:10.1016/s0022-5347(01)63299-3 · Cited by 591
Energetics of Ligand Binding to Proteins
Weber, G. (1975) · Advances in Protein Chemistry · doi:10.1016/s0065-3233(08)60410-6 · Cited by 523
Multiple cyclic nucleotide phosphodiesterases.
Beavo, J. A., Conti, M., & Heaslip, R. J. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09714-7 · Cited by 472
Moro, M. A., Russel, R. J., Cellek, S., Lizasoain, I., Su, Y., Darley-Usmar, V. M., Radomski, M. W., & Moncada, S. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.4.1480 · Cited by 471
Structure, Localization, and Regulation of cGMP-inhibited Phosphodiesterase (PDE3)
Degerman, E., Belfrage, P., & Manganiello, V. C. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.11.6823 · Cited by 428
SCHULTZ, K.-D., SCHULTZ, K., & SCHULTZ, G. (1977) · Nature · doi:10.1038/265750a0 · Cited by 419
Distinct and specific functions of cGMP-dependent protein kinases
Lohmann, S. M., Vaandrager, A. B., Smolenski, A., Walter, U., & De Jonge, H. R. (1997) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(97)01086-4 · Cited by 384
Isolation and Characterization of PDE9A, a Novel Human cGMP-specific Phosphodiesterase
Fisher, D. A., Smith, J. F., Pillar, J. S., Denis, S. H. S., & Cheng, J. B. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.25.15559 · Cited by 341
Recent Progress in Understanding the Hormonal Regulation of Phosphodiesterases
Conti, M., Némoz, G., Sette, C., & Vicini, E. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-3-370 · Cited by 312
Garbers, D. L., & Lowe, D. G. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47339-5 · Cited by 294
Identification and Characterization of a Novel Family of Cyclic Nucleotide Phosphodiesterases
Soderling, S. H., Bayuga, S. J., & Beavo, J. A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.25.15553 · Cited by 283
Jiang, H., Colbran, J. L., Francis, S. H., & Corbin, J. D. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)48388-3 · Cited by 271
Self-citationCloning and characterization of a cAMP-specific cyclic nucleotide phosphodiesterase
Soderling, S. H., Bayuga, S. J., & Beavo, J. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.15.8991 · Cited by 271
JEREMY, J. Y., BALLARD, S. A., NAYLOR, A. M., MILLER, M. A. W., & ANGELINI, G. D. (1997) · British Journal of Urology · doi:10.1046/j.1464-410x.1997.00206.x · Cited by 241
Characterization of a purified bovine lung cGMP-binding cGMP phosphodiesterase.
Thomas, M. K., Francis, S. H., & Corbin, J. D. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)77210-4 · Cited by 226
Self-citationLoughney, K., Hill, T. R., Florio, V. A., Uher, L., Rosman, G. J., Wolda, S. L., A. Jones, B., Howard, M. L., McAllister-Lucas, L. M., Sonnenburg, W. K., et al. (1998) · Gene · doi:10.1016/s0378-1119(98)00303-5 · Cited by 218
Self-citation[13] Nitric oxide-cyclic GMP signal transduction system
Hobbs, A. J., & Ignarro, L. J. (1996) · Methods in Enzymology · doi:10.1016/s0076-6879(96)69016-8 · Cited by 181
McAllister-Lucas, L. M., Sonnenburg, W. K., Kadlecek, A., Seger, D., Trong, H. L., Colbran, J. L., Thomas, M. K., Walsh, K. A., Francis, S. H., & Corbin, J. D. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)41607-9 · Cited by 169
Self-citationFrancis, S. H., Colbran, J. L., McAllister‐Lucas, L. M., & Corbin, J. D. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31669-1 · Cited by 154
Self-citationBolger, G. B. (1994) · Cellular Signalling · doi:10.1016/0898-6568(94)90018-3 · Cited by 138
Sonnenburg, W. K., Seger, D., Kwak, K. S., Huang, J., Charbonneau, H., & Beavo, J. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.52.30989 · Cited by 130
Sildenafil Inhibits Phosphodiesterase Type 5 in Human Clitoral Corpus Cavernosum Smooth Muscle
Park, K., Moreland, R. B., Goldstein, I., Atala, A., & Traish, A. M. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9206 · Cited by 129
Structure and physiological role of cGMP-dependent protein kinase
Hofmann, F. B., Dostmann, W. R., Keilbach, A., Landgraf, W., & Ruth, P. (1992) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/0167-4889(92)90165-8 · Cited by 127
Guanosine 3':5'-cyclic monophosphate binding proteins in rat tissues.
Lincoln, T., Hall, C. L., Park, C. R., & Corbin, J. D. (1976) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.73.8.2559 · Cited by 127
Self-citationSanchez, L. S., de la Monte, S. M., Filippov, G., Jones, R. C., Zapol, W. M., & Bloch, K. D. (1998) · Pediatric Research · doi:10.1203/00006450-199802000-00002 · Cited by 119
Fortnightly review: Update on male erectile dysfunction
Wagner, G., & de Tejada, I. S. (1998) · BMJ · doi:10.1136/bmj.316.7132.678 · Cited by 97
Kotera, J., Yanaka, N., Fujishige, K., Imai, Y., Akatsuka, H., Ishizuka, T., Kawashima, K., & Omori, K. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.t01-1-00434.x · Cited by 89
THE ASSAY OF GLUCAGON AND EPINEPHRINE WITH USE OF LIVER HOMOGENATES
Berthet, J., Sutherland, E. W., & Rall, T. W. (1957) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)70622-4 · Cited by 73
Zinc Dependent Activation of cAMP-Specific Phosphodiesterase (PDE4A)
Percival, M. D., Yeh, B., & Falgueyret, J. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.7542 · Cited by 63
Florio, V. A., Sonnenburg, W. K., Johnson, R. S., Kwak, K. S., Jensen, G. S., Walsh, K. A., & Beavo, J. A. (1994) · Biochemistry · doi:10.1021/bi00196a012 · Cited by 60
Cyclic GMP : synthesis, metabolism, and function
Murad, F. (1994) · Cited by 57
Houslay, M. D. (1995) · Advances in Enzyme Regulation · doi:10.1016/0065-2571(94)00012-r · Cited by 33
Cited by
Sildenafil Citrate Therapy for Pulmonary Arterial Hypertension
Galiè, N., Ghofrani, H. A., Torbicki, A., Barst, R. J., Rubin, L. J., Badesch, D., Fleming, T., Parpia, T., Burgess, G., Branzi, A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050010 · Cited by 2,476
Guanylyl Cyclases and Signaling by Cyclic GMP
Lucas, K. A., Pitari, G. M., Kazerounian, S., Ruiz-Stewart, I., Park, J., Schulz, S., Chepenik, K. P., & Waldman, S. A. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01457-1 · Cited by 1,224
cGMP-Dependent Protein Kinases and cGMP Phosphodiesterases in Nitric Oxide and cGMP Action
Francis, S. H., Busch, J. L., & Corbin, J. D. (2010) · Pharmacological Reviews · doi:10.1124/pr.110.002907 · Cited by 1,028
Self-citationPulmonary Arterial Hypertension
McLaughlin, V. V., & McGoon, M. D. (2006) · Circulation · doi:10.1161/circulationaha.104.503540 · Cited by 664
Sildenafil: from angina to erectile dysfunction to pulmonary hypertension and beyond
Ghofrani, H. A., Osterloh, I. H., & Grimminger, F. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2030 · Cited by 629
Metadata
- Authors
- Corbin, J. D., & Francis, S. H.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1999-05
- Volume
- 274
- Issue
- 20
- Pages
- 13729-13732
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2045150258
- Cited by
- 531
- References
- 41
- FWCI
- 9.35
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.